The new specific therapy for myocarditis with ghrelin
The new specific therapy for myocarditis with ghrelin
批准号:
24790761
负责人:
UEMATSU Etsuko
金额:
$2.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31
中文摘要
方法:免疫雄性Lewis大鼠,建立自身免疫性心肌炎模型。从第一次肌球蛋白注射后的3周开始,给予Ghrelin或赋形剂治疗3周。第一次免疫6周后,通过超声心动图、血流动力学、病理学和心肌基因表达来评估心肌炎的严重程度。Ghrelin可改善恶化的左室短轴缩短率和左心室扩大。在一项血流动力学研究中,服用Ghrelin的大鼠左室舒张末压显著降低。Ghrelin显著抑制左室壁形态计量型胶原体积分数的增加。有趣的是,Ghrelin治疗降低了心肌炎大鼠心脏干扰素-γ和白介素2的基因表达,增加了白介素4和白介素10的基因表达。总之,给予Ghrelin可能通过调节辅助性T细胞的激活来改善心肌炎大鼠的左心功能。
英文摘要
Methods: Male Lewis rats were immunized and autoimmune myocarditis was induced. From the 3 weeks after the first myosin injection, ghrelin or vehicle were administered for 3 weeks. Six weeks after the first immunization, the severity of myocarditis was evaluated by echocardiography, hemodynamics, pathology, and gene expressions in myocardium. Ghrelin improved the deteriorated left ventricular (LV) fractional shortening and LV enlargement. In a hemodynamic study, there was a substantial decrease in LV end-diastolic pressure in ghrelin-treated rats. Ghrelin markedly attenuated an increase in morphometrical collagen volume fraction in LV. Interestingly, the treatment of ghrelin decreased the mRNA expression of interferon -gamma and interleukin (IL) -2 and increased the mRNA expression of IL-4 and IL-10 in the heart of rats with myocarditis. In conclusion, administration of ghrelin improved LV dysfunction in rats with myocarditis probably via the modulation of helper T cell activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ghrelin Ameliorates the Progression of Experimental Autoimmune Myocarditis.
生长素释放肽可改善实验性自身免疫性心肌炎的进展。
DOI:
--
发表时间:
2014
期刊:
影响因子:
--
作者:
[Bando S, Soeki T, Hara T, Takashima A, Bando M, Ogasawara K, Saito Y, Matsuura T, Hotchi J, Kimura E, Ise T, Tobiume T, Yamaguchi K, Yagi S, Iwase T, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Kangawa K, Sata M.]
通讯作者:
Sata M.
Mechanism of cardiac-specific inflammation mediated by PAR-2 signaling and development of new cardiac disease therapies
-
批准号:20K08492
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.41万
-
财政年份:2020
-
负责人:UEMATSU Etsuko
-
依托单位:
The multifaceted effects of C-type natriuretic peptide on refractory cardiovascular disease
-
批准号:26860564
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.41万
-
财政年份:2014
-
负责人:UEMATSU Etsuko
-
依托单位: